AI in Healthcare

AI in Healthcare Market: $120 Billion by 2028. This pivotal growth trajectory highlights the transformative potential of AI in healthcare. However, it also underscores the need for robust regulatory frameworks to ensure patient safety and efficacy. Most FDA-cleared medical AI devices lack real-world testing, raising questions about their actual patient benefits. The FDA is actively seeking public input on various aspects of AI medical device regulation, including the testing of generative AI devices. This ongoing process indicates a need for clearer guidelines to ensure the safe and effective integration of AI in healthcare. [Source: Real Publisher] · Published August 20, 2026 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III Director, ALEX Companies; Associate Broker, Alexander Tiffany Southwest, LLC. +1 713.918.9951 · [email protected]
Download the PDFDownload the video
Slide 1Slide 2Slide 3Slide 4
Licensed by the Texas Real Estate Commission. Broker: Alexander Tiffany Southwest, LLC · License #565194-BB.
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B  ·  George Arnold Alexander III, Director, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov